scholarly journals Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

2018 ◽  
Vol 20 (5) ◽  
pp. 1148-1155 ◽  
Author(s):  
Chantal Mathieu ◽  
Bruce W. Bode ◽  
Edward Franek ◽  
Athena Philis‐Tsimikas ◽  
Ludger Rose ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Phase Iii ◽  
Treat To Target ◽  
Efficacy And Safety ◽  
Phase Iii Trial ◽  
Diabetes Onset ◽  
Acting Insulin ◽  
Fast Acting

Glycemic Control with Fast-Acting Insulin Aspart According to Dose Adjustment Method in Type 1 Diabetes: A Post Hoc Analysis of Onset 8

2018 ◽  
Vol 42 (5) ◽  
pp. S47
Author(s):  
Rémi Rabasa-Lhoret ◽  
Thomas R. Pieber ◽  
John B. Buse ◽  
Ludger Rose ◽  
Anders Gorst-Rasmussen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Insulin Aspart ◽  
Dose Adjustment ◽  
Post Hoc Analysis ◽  
Adjustment Method ◽  
Acting Insulin ◽  
Post Hoc ◽  
Fast Acting
Sign in / Sign up

Export Citation Format

Share Document